This is a routine dividend; no strategic shift or financial change is indicated. Traders should monitor for any future adjustments in payout ratio or yield signaling a policy shift.
RPRX drugs
RPRX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 17 $50.00entry
- T+1 · 7mo ago −1.40%α −1.21% · $49.30
- T+5 · 7mo ago −1.24%α −1.79% · $49.38
- T+20 · 6mo ago +6.80%α +1.43% · $53.40
- T+60 · 4mo ago +11.34%α +5.20% · $55.67
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Royalty Pharma announced a quarterly dividend of $0.235 per share, payable June 10, 2026, to shareholders of record as of May 15, 2026. This is a routine capital return with no change in dividend policy or magnitude.
Key Facts
- Royalty Pharma declared a quarterly dividend of $0.235 per Class A ordinary share.
- Dividend payable on June 10, 2026, to shareholders of record on May 15, 2026.
- No change in dividend amount or policy announced.
Financial Impact
Approximately $138 million quarterly (based on ~587 million shares outstanding and $28B market cap)
Risk Factors
- Ongoing insider selling ($1.6M in the last 30 days) may signal muted confidence despite stable dividends.
- Pharma royalty models are sensitive to drug lifecycle risk and patent expirations, though not reflected in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3276138 |
Track record
23 reports on RPRX
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.20% at T+60 after the May 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry price pending
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $67.57 to $68.97 Now $68.53 +1.41% ▲ +2.07% −1.22% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $67.56 to $70.01 Now $68.53 +1.43% ▲ +3.63% +4.54% vs SPY
- Sep 30, 20266w ago Insider Cluster Bearish 5/10 Entry $57.63 to $56.21 Now $68.53 −18.91% ▲ +2.46% +3.77% vs SPY
- Sep 4, 202610w ago Press Release Bearish 5/10 Entry $60.59 to $58.47 Now $68.53 −13.10% ▲ +3.50% +2.38% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 3/10 Entry $60.57 to $61.92 Now $68.53 +13.14% ▲ +2.24% +1.12% vs SPY
- Aug 12, 202613w ago 144 Neutral 3/10 Entry $58.56 to $60.58 Now $68.53 +17.02% ▲ +3.45% +5.41% vs SPY
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $57.75 to $59.22 Now $68.53 +18.66% ▲ +2.55% +2.19% vs SPY
- Jul 2, 202619w ago Insider Cluster Neutral 2/10 Entry $57.77 to $57.96 Now $68.53 +18.62% ▲ +0.33% −0.60% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers